Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Insulin Lispro 25%(R Dna Origin ) & 75% Insulin Lispro Protamine Suspension Inj. 100 Iu/ Ml - 3 Ml Pen Injection

BLW HQ-STORES BLW India has Released a tender for Insulin Lispro 25%(R Dna Origin ) & 75% Insulin Lispro Protamine Suspension Inj. 100 Iu/ Ml - 3 Ml Pen Injection in Healthcare and Medicine. The tender was released on Jul 14, 2025.

Country - India

Summary - Insulin Lispro 25%(R Dna Origin ) & 75% Insulin Lispro Protamine Suspension Inj. 100 Iu/ Ml - 3 Ml Pen Injection

Deadline - login to view

GT reference number - 113333090

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - India

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 113333090

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Insulin Lispro 25%(R Dna Origin ) & 75% Insulin Lispro Protamine Suspension Inj. 100 Iu/ Ml - 3 Ml Pen Injectionlocal title:: INSULIN LISPRO 25%(r DNA ORIGIN ) & 75% INSULIN LISPRO PROTAMINE SUSPENSION INJ. 100 IU/ ML - 3 ML PEN INJECTI ONContract Type: : Supply

Gt Ref Id - 113333090

Deadline - Jul 23, 2025

Share share

Similar Tenders :

Summary:
Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database